PRODexcom Inc
stock85.92
+1.81 (+2.15%)
Price as of 13 Oct, 12:11 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Bullish
2 bull · 1 bear · 2 neutral
Medium-Term Outlook
Bearish
1 bull · 3 bear · 0 neutral
Price below 50-day MA
Price above 200-day MA
Price above 12-day EMA
Price below 26-day EMA
Neutral momentum zone
MACD below signal line
%K above %D
Price near middle band
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+1.81
Market Cap
29577165000
Exchange
NASDAQ
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Dexcom Inc
What is Dexcom Inc?
Dexcom Inc is a medical device company that specializes in continuous glucose monitoring (CGM) systems for people with diabetes. Their wearable sensors measure glucose levels in real-time and transmit data to a receiver or smartphone app, helping users manage their condition without frequent fingersticks. The company is a key player in the digital health sector, focusing on improving patient outcomes through remote monitoring technology.
Is Dexcom Inc a good investment?
Dexcom benefits from a growing market for diabetes management and strong brand loyalty, but it faces increasing competition from other medical technology firms and potential price pressure on their devices. Its stock performance often relies on its ability to maintain technological innovation and expand insurance coverage for its products. Please note that this information is for educational purposes only and does not constitute financial advice.
How do you invest in Dexcom Inc?
You can invest in Dexcom by purchasing shares directly through a brokerage account by searching for the ticker symbol DXCM. Alternatively, you can gain indirect exposure by investing in health care-focused exchange-traded funds (ETFs) that include Dexcom among their holdings. Ensure you research the commission fees and minimum deposit requirements of your chosen trading platform before starting.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for DXCM — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 13 Oct 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding DXCM
Jim Simons
1.63M sh · 0.2% of portfolio
$109.83M
NEW
Ken Griffin
90.14M sh · 0.0% of portfolio
$84.21M
NEW
Ken Griffin
1.13M sh · 0.0% of portfolio
$75.86M
NEW
Ken Griffin
960.0K sh · 0.0% of portfolio
$64.66M
NEW
Ray Dalio
400.9K sh · 0.1% of portfolio
$27.00M
NEW
Ken Griffin
382.6K sh · 0.0% of portfolio
$25.77M
NEW
Ken Griffin
206.2K sh · 0.0% of portfolio
$13.89M
NEW
Ken Griffin
85.3K sh · 0.0% of portfolio
$5.75M
NEW
Ken Fisher
61.1K sh · 0.0% of portfolio
$4.12M
NEW
Mario Gabelli
52.0K sh · 0.0% of portfolio
$3.50M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.